{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:35:34Z","timestamp":1790908534395,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canlet.2025.217702","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:54:35Z","timestamp":1744134875000},"page":"217702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory\/ineligible head and neck cancer in palliative setting with survival outcomes"],"prefix":"10.1016","volume":"621","author":[{"given":"Rushabh","family":"Kothari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-5916","authenticated-orcid":false,"given":"Ravi krishna","family":"Madala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas T.","family":"Talreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Shrirangwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5679-7790","authenticated-orcid":false,"given":"Tanmoy Kumar","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Turkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5373-0558","authenticated-orcid":false,"given":"Arun","family":"Chandrasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara Chand","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Poladia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuprasad","family":"Avaronnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovin","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitali","family":"Alone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Kolkur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8310-619X","authenticated-orcid":false,"given":"Priyanka","family":"Bhagyavant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Peelay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurang","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itesh","family":"Khatwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1710-1594","authenticated-orcid":false,"given":"Gautam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Madankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nibedita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Sonwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Muley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajith Babu","family":"Thavarool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Katna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepan","family":"Rajamanickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravana","family":"Rajamanickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Kumar","family":"Shenoy Vp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashay","family":"Karpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.D.","family":"Banavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-5004","authenticated-orcid":false,"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217702_bib1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217702_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canlet.2025.217702_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.22.01015","article-title":"Low-dose immunotherapy in head and neck cancer: a randomized study","volume":"41","author":"Patil","year":"2023","journal-title":"J Clin Oncol."},{"issue":"18","key":"10.1016\/j.canlet.2025.217702_bib4","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1002\/cncr.32179","article-title":"A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer","volume":"125","author":"Patil","year":"2019","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2025.217702_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.2017.74.9457","article-title":"Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial","volume":"36","author":"Noronha","year":"2018","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.canlet.2025.217702_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4103\/crst.crst_203_22","article-title":"Paclitaxel with Mycidac-C in the second line and beyond in advanced head-and-neck cancer: a retrospective analysis from a tertiary cancer center","volume":"5","author":"Sarma","year":"2022","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in Oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.canlet.2025.217702_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100309","article-title":"Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck","volume":"6","author":"Keam","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2025.217702_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/crst.crst_185_22","article-title":"Nivolumab in platinum-refractory head-and-neck cancers: a retrospective observational audit from a tertiary cancer center","volume":"5","author":"Patil","year":"2022","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3332\/ecancer.2022.1464","article-title":"Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India","volume":"16","author":"Patil","year":"2022","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.canlet.2025.217702_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7727\/wimj.2013.04","article-title":"An evaluation of treatment strategies for head and neck cancer in a... - PubMed - NCBI","volume":"62","author":"Ignacio","year":"2013","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.canlet.2025.217702_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4103\/crst.crst_157_21","article-title":"Post hoc analysis of the screening log of phase III investigator-initiated randomized clinical trial comparing palliative oral metronomic versus intravenous chemotherapy in head-and-neck cancer","volume":"4","author":"Dhumal","year":"2021","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/CRST.CRST_90_19","article-title":"Oral etoposide and cyclophosphamide: a low-cost palliative metronomic chemotherapy in advanced pediatric cancers","volume":"3","author":"Kumar","year":"2020","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib14","doi-asserted-by":"crossref","first-page":"e1213","DOI":"10.1016\/S2214-109X(20)30275-8","article-title":"Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial","volume":"8","author":"Patil","year":"2020","journal-title":"Lancet Global Health"},{"issue":"32","key":"10.1016\/j.canlet.2025.217702_bib15","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.19.01076","article-title":"Phase I\/II study of palliative triple metronomic chemotherapy in platinum-refractory\/early-failure oral cancer","volume":"37","author":"Patil","year":"2019","journal-title":"J Clin Oncol JCO"},{"key":"10.1016\/j.canlet.2025.217702_bib16","unstructured":"https:\/\/ctri.nic.in\/Clinicaltrials."},{"key":"10.1016\/j.canlet.2025.217702_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.oraloncology.2017.10.018","article-title":"Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer","volume":"75","author":"Joshi","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2025.217702_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/CRST.CRST_5_18","article-title":"A step-wise guide to performing survival analysis","volume":"1","author":"Chakraborty","year":"2018","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/CRST.CRST_7_19","article-title":"Stepwise Cox regression analysis in SPSS","volume":"1","author":"Dessai","year":"2018","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/CRST.CRST_40_19","article-title":"Testing and interpreting assumptions of COX regression analysis","volume":"2","author":"Dessai","year":"2019","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.oraloncology.2016.10.023","article-title":"Expectations and preferences for palliative chemotherapy in head and neck cancers patients","volume":"63","author":"Patil","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2025.217702_bib22","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/crst.crst_124_23","article-title":"Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: update 2022","volume":"7","author":"Noronha","year":"2024","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.canlet.2025.217702_bib23","first-page":"231","article-title":"Adherence to targeted oral anticancer medications","volume":"15","author":"Geynisman","year":"2013","journal-title":"Discov. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:59:58Z","timestamp":1760741998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352500268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":23,"alternative-id":["S030438352500268X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217702","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory\/ineligible head and neck cancer in palliative setting with survival outcomes","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217702"}}